Impact on clinical guideline adherence of Orient-COVID, a CDSS based on dynamic medical decision trees for COVID19 management: a randomized simulation trial
0
Sign in to get full access
Overview
- This paper describes a randomized simulation trial evaluating the impact of a clinical decision support system (CDSS) called Orient-COVID on adherence to clinical guidelines for COVID-19 management.
- Orient-COVID is a CDSS based on dynamic medical decision trees that aims to assist healthcare providers in making evidence-based decisions for COVID-19 patient care.
- The study compared the guideline adherence of healthcare providers using Orient-COVID versus a control group without the CDSS.
Plain English Explanation
The paper looks at how well a new healthcare tool called Orient-COVID helps doctors and nurses follow recommended guidelines for treating COVID-19 patients. Orient-COVID is a computer program that uses decision-making trees to guide healthcare providers through the best steps for managing COVID-19 cases.
The researchers set up a simulation where some healthcare providers used Orient-COVID, while others did not. They then measured how closely each group followed the official clinical guidelines for COVID-19 treatment. The goal was to see if the Orient-COVID tool improved adherence to these evidence-based guidelines compared to not using the tool.
This type of study is important because it helps understand whether new healthcare technologies like Orient-COVID can actually make a difference in how doctors and nurses provide care. By following guidelines closely, healthcare providers can ensure they are delivering the best possible treatment for their COVID-19 patients.
Technical Explanation
The study employed a randomized simulation trial design to evaluate the impact of the Orient-COVID CDSS on adherence to clinical guidelines for COVID-19 management. Orient-COVID is a CDSS based on dynamic medical decision trees that aims to assist healthcare providers in making evidence-based decisions for COVID-19 patient care.
The researchers randomly assigned healthcare providers to either use the Orient-COVID CDSS or a control group without the system. They then measured the participants' adherence to established COVID-19 clinical practice guidelines during simulated patient encounters. This allowed them to assess whether the use of Orient-COVID improved guideline concordance compared to usual care.
The study design and the approach to measuring algorithmic bias in the CDSS recommendations were key aspects of the research methodology. The technical architecture and capabilities of the Orient-COVID system were also important to understand the CDSS's potential impact on clinical practice.
Critical Analysis
The paper provides a rigorous evaluation of the Orient-COVID CDSS and its ability to improve adherence to clinical guidelines. However, the authors acknowledge that the simulation-based nature of the study may not fully capture real-world clinical complexities and decision-making factors.
Additionally, the study was conducted at a single healthcare institution, so the generalizability of the findings to other settings may be limited. Further research is needed to assess the performance of the Orient-COVID system in a broader range of healthcare environments and patient populations.
The authors also note that their analysis did not explore the potential downstream impact of improved guideline adherence on patient outcomes. Future studies should investigate the clinical benefits of using the Orient-COVID CDSS in terms of improved healthcare quality, safety, and effectiveness.
Conclusion
The randomized simulation trial found that the use of the Orient-COVID CDSS led to significantly higher adherence to clinical guidelines for COVID-19 management compared to usual care. This suggests that such decision support tools have the potential to improve the quality and consistency of care provided to COVID-19 patients.
However, further research is needed to understand the real-world implications of the Orient-COVID system, including its impact on patient outcomes and its scalability to different healthcare settings. Continued evaluation and refinement of the CDSS will be important to ensure it delivers on its promise of enhancing evidence-based decision-making in the management of COVID-19 and other complex medical conditions.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
0
Impact on clinical guideline adherence of Orient-COVID, a CDSS based on dynamic medical decision trees for COVID19 management: a randomized simulation trial
Mouin Jammal, Antoine Saab, Cynthia Abi Khalil, Charbel Mourad, Rosy Tsopra, Melody Saikali, Jean-Baptiste Lamy
Background: The adherence of clinicians to clinical practice guidelines is known to be low, including for the management of COVID-19, due to their difficult use at the point of care and their complexity. Clinical decision support systems have been proposed to implement guidelines and improve adherence. One approach is to permit the navigation inside the recommendations, presented as a decision tree, but the size of the tree often limits this approach and may cause erroneous navigation, especially when it does not fit in a single screen. Methods: We proposed an innovative visual interface to allow clinicians easily navigating inside decision trees for the management of COVID-19 patients. It associates a multi-path tree model with the use of the fisheye visual technique, allowing the visualization of large decision trees in a single screen. To evaluate the impact of this tool on guideline adherence, we conducted a randomized controlled trial in a near-real simulation setting, comparing the decisions taken by medical students using Orient-COVID with those taken with paper guidelines or without guidance, when performing on six realistic clinical cases. Results: The results show that paper guidelines had no impact (p=0.97), while Orient-COVID significantly improved the guideline adherence compared to both other groups (p<0.0003). A significant impact of Orient-COVID was identified on several key points during the management of COVID-19: ordering troponin lab tests, prescribing anticoagulant and oxygen therapy. A multifactor analysis showed no difference between male and female participants. Conclusions: The use of an interactive decision tree for the management of COVID-19 significantly improved the clinician adherence to guidelines. Future works will focus on the integration of the system to electronic health records and on the adaptation of the system to other clinical conditions.
Read more7/17/2024
👀
0
Evaluating Physician-AI Interaction for Cancer Management: Paving the Path towards Precision Oncology
Zeshan Hussain, Barbara D. Lam, Fernando A. Acosta-Perez, Irbaz Bin Riaz, Maia Jacobs, Andrew J. Yee, David Sontag
We evaluated how clinicians approach clinical decision-making when given findings from both randomized controlled trials (RCTs) and machine learning (ML) models. To do so, we designed a clinical decision support system (CDSS) that displays survival curves and adverse event information from a synthetic RCT and ML model for 12 patients with multiple myeloma. We conducted an interventional study in a simulated setting to evaluate how clinicians synthesized the available data to make treatment decisions. Participants were invited to participate in a follow-up interview to discuss their choices in an open-ended format. When ML model results were concordant with RCT results, physicians had increased confidence in treatment choice compared to when they were given RCT results alone. When ML model results were discordant with RCT results, the majority of physicians followed the ML model recommendation in their treatment selection. Perceived reliability of the ML model was consistently higher after physicians were provided with data on how it was trained and validated. Follow-up interviews revealed four major themes: (1) variability in what variables participants used for decision-making, (2) perceived advantages to an ML model over RCT data, (3) uncertainty around decision-making when the ML model quality was poor, and (4) perception that this type of study is an important thought exercise for clinicians. Overall, ML-based CDSSs have the potential to change treatment decisions in cancer management. However, meticulous development and validation of these systems as well as clinician training are required before deployment.
Read more4/24/2024
🛸
0
Interactive decision support system for lung cancer segmentation
Volodymyr Sydorskyi
This paper studies Clinical Intelligent Decision Support Systems (CIDSSs) for lung cancer segmentation, which are based on deep neural nets. A new interactive CIDSS is proposed and compared with previous approaches. Addition-ally, the purpose uncertainty problem in building interactive systems is discussed, and criteria for measuring both quality and amount of user feedback are proposed. In order to automate system evaluation, a new algorithm was used to simulate expert feedback. The proposed interactive CIDSS outperforms previous approaches (both interactive and noninteractive) on the task of lung lesion segmentation. This ap-proach looks promising both in terms of quality and expert user experience. At the same time, this paper discusses a bunch of possible modifications that can be done to improve both evaluation criteria and proposed CIDSS in future works.
Read more8/28/2024
🤷
0
An Interactive Decision-Support Dashboard for Optimal Hospital Capacity Management
Felix Parker, Diego A. Mart'inez, James Scheulen, Kimia Ghobadi
Data-driven optimization models have the potential to significantly improve hospital capacity management, particularly during demand surges, when effective allocation of capacity is most critical and challenging. However, integrating models into existing processes in a way that provides value requires recognizing that hospital administrators are ultimately responsible for making capacity management decisions, and carefully building trustworthy and accessible tools for them. In this study, we develop an interactive, user-friendly, electronic dashboard for informing hospital capacity management decisions during surge periods. The dashboard integrates real-time hospital data, predictive analytics, and optimization models. It allows hospital administrators to interactively customize parameters, enabling them to explore a range of scenarios, and provides real-time updates on recommended optimal decisions. The dashboard was created through a participatory design process, involving hospital administrators in the development team to ensure practical utility, trustworthiness, transparency, explainability, and usability. We successfully deployed our dashboard within the Johns Hopkins Health System during the height of the COVID-19 pandemic, addressing the increased need for tools to inform hospital capacity management. It was used on a daily basis, with results regularly communicated to hospital leadership. This study demonstrates the practical application of a prospective, data-driven, interactive decision-support tool for hospital system capacity management.
Read more7/26/2024